Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2025)
Vir Biotechnology's Depreciation and Depletion history spans 3 years, with the latest figure at $2.8 million for Q4 2025.
- On a quarterly basis, Depreciation and Depletion rose 3.7% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.4 million, a 19.72% decrease, with the full-year FY2025 number at $11.4 million, down 19.72% from a year prior.
- Depreciation and Depletion hit $2.8 million in Q4 2025 for Vir Biotechnology, down from $2.9 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for VIR hit a ceiling of $5.5 million in Q1 2023 and a floor of $2.7 million in Q4 2024.
- Historically, Depreciation and Depletion has averaged $3.7 million across 3 years, with a median of $3.6 million in 2024.
- Biggest five-year swings in Depreciation and Depletion: tumbled 37.21% in 2024 and later grew 3.7% in 2025.
- Tracing VIR's Depreciation and Depletion over 3 years: stood at $4.3 million in 2023, then tumbled by 37.21% to $2.7 million in 2024, then grew by 3.7% to $2.8 million in 2025.
- Business Quant data shows Depreciation and Depletion for VIR at $2.8 million in Q4 2025, $2.9 million in Q3 2025, and $2.9 million in Q2 2025.